PRESS RELEASE
18 February 2021

You're Invited — Apply Now To Compete In The 2021 M2D2 $200K Challenge!

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Mintz is proud to sponsor this 10th annual competition. Now is your opportunity to apply! M2D2, the Massachusetts Medical Device Development Center...
United States

Mintz is proud to sponsor this 10th annual competition. Now is your opportunity to apply! M2D2, the Massachusetts Medical Device Development Center, is looking for early- to mid-stage start-ups in the medical device, diagnostic, and biotech spaces to compete in its annual challenge. This year, up to 20 finalists will be selected to share $200K in sponsor-provided, in-kind prizes — including lab and office space as well as engineering, product development, legal, regulatory, clinical, and business services.

Key Dates

February 15 February 19: Application Deadline — EXTENDED!

March 5: Finalists Announced

March 24: Finalist Pitch-Off

April 7: Awards Celebration

Learn more about the competition at the M2D2 $200K Challenge page.

ENTER NOW

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More